Ccr5 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
CCR5 (C-C Chemokine Receptor Type 5) is a G protein-coupled receptor that serves as a major co-receptor for HIV-1 entry and plays crucial roles in immune cell trafficking and neuroinflammation. As a chemokine receptor, CCR5 mediates the recruitment of immune cells to sites of inflammation and is expressed on various cell types in the central nervous system, including microglia and astrocytes. Dysregulation of CCR5 signaling contributes to chronic neuroinflammation in neurodegenerative diseases, making it both a therapeutic target and a modulator of disease progression. [1]
| Attribute | Value | [2]
|-----------|-------| [3]
| Symbol | CCR5 | [4]
| Full Name | C-C Chemokine Receptor Type 5 | [5]
| Chromosomal Location | 3p21.31 | [6]
| NCBI Gene ID | 1234 |
| Ensembl ID | ENSG00000160791 |
| UniProt | P51681 |
CCR5 is a 352-amino acid G protein-coupled receptor (GPCR) with characteristic seven-transmembrane domain architecture:
The crystal structure (PDB: 5UIW) reveals the binding pockets for both endogenous chemokines and small molecule antagonists like maraviroc. The receptor exists as a monomer and can form homodimers or heterodimers with other chemokine receptors.
CCR5 functions as a chemokine receptor through the following mechanisms:
Ligand Binding: Binds multiple CC chemokines including:
Signal Transduction:
Cellular Effects:
Viral Co-receptor Function:
CCR5 is expressed on multiple cell types:
Immune Cells:
Central Nervous System:
In the brain, CCR5 expression increases during neuroinflammation, with highest expression on activated microglia surrounding amyloid plaques in Alzheimer's disease and in the substantia nigra in Parkinson's disease.
| Agent | Mechanism | Status | Indication |
|---|---|---|---|
| Maraviroc | CCR5 antagonist | FDA-approved | HIV infection |
| Vicriviroc | CCR5 antagonist | Clinical trials | HIV infection |
| Aplaviroc | CCR5 antagonist | Discontinued | Liver toxicity |
| CCR5 antibodies | Neutralizing antibodies | Preclinical | Research use |
| CCR5-targeting siRNA | Gene silencing | Preclinical | Experimental |
Neurological Applications:
Ccr5 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Ccr5 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.